25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

6MK (Merck & Co. Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Merck & Co. Inc together

I guess you are interested in Merck & Co. Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Merck & Co. Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Merck & Co. Inc’s Price Targets

I'm going to help you getting a better view of Merck & Co. Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Merck & Co. Inc

I send you an email if I find something interesting about Merck & Co. Inc.

1. Quick Overview

1.1. Quick analysis of Merck & Co. Inc (30 sec.)










1.2. What can you expect buying and holding a share of Merck & Co. Inc? (30 sec.)

How much money do you get?

How much money do you get?
€3.14
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€16.29
Expected worth in 1 year
€19.06
How sure are you?
86.4%

+ What do you gain per year?

Total Gains per Share
€5.43
Return On Investment
7.8%

For what price can you sell your share?

Current Price per Share
€69.70
Expected price per share
€65.64 - €70.30
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Merck & Co. Inc (5 min.)




Live pricePrice per Share (EOD)
€69.70
Intrinsic Value Per Share
€-7.57 - €-11.05
Total Value Per Share
€8.72 - €5.24

2.2. Growth of Merck & Co. Inc (5 min.)




Is Merck & Co. Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$48.3b$39.5b$6.2b13.6%

How much money is Merck & Co. Inc making?

Current yearPrevious yearGrowGrow %
Making money$4.3b$576.4m$3.7b86.8%
Net Profit Margin27.4%2.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Merck & Co. Inc (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#14 / 205

Most Revenue
#16 / 205

Most Profit
#7 / 205
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Merck & Co. Inc?

Welcome investor! Merck & Co. Inc's management wants to use your money to grow the business. In return you get a share of Merck & Co. Inc.

First you should know what it really means to hold a share of Merck & Co. Inc. And how you can make/lose money.

Speculation

The Price per Share of Merck & Co. Inc is €69.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Merck & Co. Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Merck & Co. Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €16.29. Based on the TTM, the Book Value Change Per Share is €0.69 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.66 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Merck & Co. Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps2.022.9%1.722.5%0.230.3%1.081.5%1.071.5%0.941.4%
Usd Book Value Change Per Share0.891.3%0.821.2%-0.63-0.9%0.250.4%0.440.6%0.871.3%
Usd Dividend Per Share0.811.2%0.791.1%0.741.1%0.741.1%0.701.0%0.691.0%
Usd Total Gains Per Share1.702.4%1.602.3%0.110.2%1.001.4%1.141.6%1.572.2%
Usd Price Per Share98.36-118.35-125.05-118.26-102.40-88.75-
Price to Earnings Ratio12.18-17.96--9.67-10.15-10.82-10.26-
Price-to-Total Gains Ratio57.78-76.45--18.85-49.15-43.46-44.39-
Price to Book Ratio5.11-6.59-8.02-6.95-6.69-6.01-
Price-to-Total Gains Ratio57.78-76.45--18.85-49.15-43.46-44.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share82.30176
Number of shares12
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.790.70
Usd Book Value Change Per Share0.820.44
Usd Total Gains Per Share1.601.14
Gains per Quarter (12 shares)19.2413.73
Gains per Year (12 shares)76.9654.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1383967342145
275791446842100
311311822110163155
415115729813585210
5188196375169106265
6226236452203127320
7264275529236148375
8302314606270169430
9339353683304190485
10377393760338212540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%17.03.00.085.0%19.03.00.086.4%19.03.00.086.4%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%17.03.00.085.0%19.03.00.086.4%19.03.00.086.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%17.03.00.085.0%19.03.00.086.4%19.03.00.086.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Merck & Co. Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7520.693+9%-0.534+171%0.214+251%0.373+101%0.740+2%
Book Value Per Share--16.28715.325+6%13.204+23%14.542+12%13.043+25%11.134+46%
Current Ratio--1.4101.401+1%1.292+9%1.378+2%1.324+7%1.307+8%
Debt To Asset Ratio--0.5800.604-4%0.627-8%0.604-4%0.627-8%0.637-9%
Debt To Equity Ratio--1.3801.533-10%1.686-18%1.536-10%1.723-20%1.803-23%
Dividend Per Share--0.6900.665+4%0.630+10%0.630+10%0.596+16%0.587+18%
Enterprise Value--153115441262.400194299776785.850-21%212195754825.500-28%197558279958.108-22%164662707936.681-7%161827673329.689-5%
Eps--1.7091.460+17%0.194+783%0.914+87%0.904+89%0.797+114%
Ev To Sales Ratio--2.9113.583-19%4.080-29%3.825-24%3.370-14%3.364-13%
Free Cash Flow Per Share--0.3941.425-72%0.922-57%1.096-64%0.980-60%0.929-58%
Free Cash Flow To Equity Per Share---1.5420.588-362%0.455-439%0.436-454%0.562-374%0.507-404%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---11.048----------
Intrinsic Value_10Y_min---7.569----------
Intrinsic Value_1Y_max--3.593----------
Intrinsic Value_1Y_min--3.532----------
Intrinsic Value_3Y_max--7.214----------
Intrinsic Value_3Y_min--6.959----------
Intrinsic Value_5Y_max--6.516----------
Intrinsic Value_5Y_min--6.356----------
Market Cap--209615630862.400253450873785.850-17%268427297125.500-22%253683901691.442-17%219570574816.681-5%190297974882.126+10%
Net Profit Margin--0.3270.274+20%0.029+1009%0.176+86%0.188+74%0.195+68%
Operating Margin----0%-0%-0%0.036-100%0.100-100%
Operating Ratio--0.8380.916-8%1.186-29%1.031-19%1.051-20%1.045-20%
Pb Ratio4.279-20%5.1146.586-22%8.023-36%6.951-26%6.689-24%6.013-15%
Pe Ratio10.195-20%12.18417.961-32%-9.672+179%10.153+20%10.817+13%10.263+19%
Price Per Share69.700-20%83.300100.225-17%105.900-21%100.150-17%86.722-4%75.160+11%
Price To Free Cash Flow Ratio44.182-20%52.80327.176+94%-4.586+109%30.841+71%31.433+68%18.056+192%
Price To Total Gains Ratio48.345-20%57.77876.446-24%-18.852+133%49.146+18%43.460+33%44.386+30%
Quick Ratio--0.4520.416+9%0.457-1%0.436+4%0.407+11%0.405+12%
Return On Assets--0.0440.038+17%0.005+750%0.024+81%0.026+72%0.027+65%
Return On Equity--0.1050.096+10%0.011+814%0.060+76%0.067+57%0.073+44%
Total Gains Per Share--1.4421.358+6%0.096+1409%0.844+71%0.969+49%1.327+9%
Usd Book Value--48395229696.00045740491372.800+6%39521354391.360+22%43486213576.320+11%38986357125.888+24%36573874923.571+32%
Usd Book Value Change Per Share--0.8880.818+9%-0.631+171%0.253+251%0.441+101%0.874+2%
Usd Book Value Per Share--19.23218.096+6%15.592+23%17.171+12%15.401+25%13.147+46%
Usd Dividend Per Share--0.8150.785+4%0.744+10%0.744+10%0.704+16%0.693+18%
Usd Enterprise Value--180798713042.642229429176428.732-21%250560747297.950-28%233276816974.534-22%194433725531.633-7%191086116667.696-5%
Usd Eps--2.0181.724+17%0.229+783%1.079+87%1.067+89%0.942+114%
Usd Free Cash Flow--1171884487.6804259330159.040-72%2759727974.400-58%3278093545.920-64%2931061086.144-60%2333689968.845-50%
Usd Free Cash Flow Per Share--0.4661.683-72%1.088-57%1.294-64%1.158-60%1.097-58%
Usd Free Cash Flow To Equity Per Share---1.8210.694-362%0.538-439%0.515-454%0.664-374%0.599-404%
Usd Market Cap--247514136922.322299274791766.332-17%316958952445.790-22%299549951117.254-17%259268934743.537-5%224703848740.815+10%
Usd Price Per Share82.302-20%98.361118.346-17%125.047-21%118.257-17%102.402-4%88.749+11%
Usd Profit--5078499413.7604358070426.240+17%576443180.160+781%2730564182.400+86%2698633996.416+88%2681295705.446+89%
Usd Revenue--15527469461.76015978924961.920-3%15348987054.720+1%15264578708.160+2%14258044588.608+9%13762123471.411+13%
Usd Total Gains Per Share--1.7021.603+6%0.113+1409%0.997+71%1.144+49%1.567+9%
 EOD+4 -2MRQTTM+23 -14YOY+23 -143Y+24 -135Y+24 -1410Y+26 -12

3.3 Fundamental Score

Let's check the fundamental score of Merck & Co. Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.195
Price to Book Ratio (EOD)Between0-14.279
Net Profit Margin (MRQ)Greater than00.327
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.452
Current Ratio (MRQ)Greater than11.410
Debt to Asset Ratio (MRQ)Less than10.580
Debt to Equity Ratio (MRQ)Less than11.380
Return on Equity (MRQ)Greater than0.150.105
Return on Assets (MRQ)Greater than0.050.044
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Merck & Co. Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose69.500
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Merck & Co. Inc

  • Other
  • 0

There is no Profile data available for 6MK.BE.

Fundamental data was last updated by Penke on 2025-06-20 22:31:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Merck & Co. Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • A Net Profit Margin of 32.7%Β means thatΒ €0.33 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Co. Inc:

  • The MRQ is 32.7%. The company is making a huge profit. +2
  • The TTM is 27.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ32.7%TTM27.4%+5.3%
TTM27.4%YOY2.9%+24.4%
TTM27.4%5Y18.8%+8.6%
5Y18.8%10Y19.5%-0.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ32.7%6.1%+26.6%
TTM27.4%5.8%+21.6%
YOY2.9%5.6%-2.7%
3Y17.6%5.9%+11.7%
5Y18.8%5.9%+12.9%
10Y19.5%6.1%+13.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Merck & Co. Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • 4.4% Return on Assets means thatΒ Merck & Co. Inc generatedΒ €0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Co. Inc:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM3.8%+0.6%
TTM3.8%YOY0.5%+3.3%
TTM3.8%5Y2.6%+1.2%
5Y2.6%10Y2.7%-0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%0.9%+3.5%
TTM3.8%0.9%+2.9%
YOY0.5%0.8%-0.3%
3Y2.4%1.0%+1.4%
5Y2.6%1.0%+1.6%
10Y2.7%1.0%+1.7%
4.3.1.3. Return on Equity

Shows how efficient Merck & Co. Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • 10.5% Return on Equity means Merck & Co. Inc generated €0.11Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Co. Inc:

  • The MRQ is 10.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.5%TTM9.6%+1.0%
TTM9.6%YOY1.1%+8.4%
TTM9.6%5Y6.7%+2.8%
5Y6.7%10Y7.3%-0.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ10.5%3.1%+7.4%
TTM9.6%2.4%+7.2%
YOY1.1%2.5%-1.4%
3Y6.0%2.8%+3.2%
5Y6.7%3.1%+3.6%
10Y7.3%3.0%+4.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Merck & Co. Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Merck & Co. Inc is operatingΒ .

  • Measures how much profit Merck & Co. Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Co. Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.6%-3.6%
5Y3.6%10Y10.0%-6.4%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%-10.8%
TTM-6.2%-6.2%
YOY-8.7%-8.7%
3Y-2.1%-2.1%
5Y3.6%2.8%+0.8%
10Y10.0%5.7%+4.3%
4.3.2.2. Operating Ratio

Measures how efficient Merck & Co. Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Other industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are €0.84 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.838. The company is less efficient in keeping operating costs low.
  • The TTM is 0.916. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.838TTM0.916-0.078
TTM0.916YOY1.186-0.270
TTM0.9165Y1.051-0.135
5Y1.05110Y1.045+0.006
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8381.491-0.653
TTM0.9161.498-0.582
YOY1.1861.519-0.333
3Y1.0311.533-0.502
5Y1.0511.515-0.464
10Y1.0451.506-0.461
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Merck & Co. Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Merck & Co. Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Other industry mean).
  • A Current Ratio of 1.41Β means the company has €1.41 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Co. Inc:

  • The MRQ is 1.410. The company is just able to pay all its short-term debts.
  • The TTM is 1.401. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.410TTM1.401+0.009
TTM1.401YOY1.292+0.109
TTM1.4015Y1.324+0.077
5Y1.32410Y1.307+0.017
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4101.393+0.017
TTM1.4011.380+0.021
YOY1.2921.503-0.211
3Y1.3781.487-0.109
5Y1.3241.522-0.198
10Y1.3071.476-0.169
4.4.3.2. Quick Ratio

Measures if Merck & Co. Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • A Quick Ratio of 0.45Β means the company can pay off €0.45 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.452. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.416. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.452TTM0.416+0.037
TTM0.416YOY0.457-0.041
TTM0.4165Y0.407+0.008
5Y0.40710Y0.405+0.003
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4520.494-0.042
TTM0.4160.482-0.066
YOY0.4570.497-0.040
3Y0.4360.495-0.059
5Y0.4070.519-0.112
10Y0.4050.555-0.150
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Merck & Co. Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Merck & Co. IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Merck & Co. Inc to Other industry mean.
  • A Debt to Asset Ratio of 0.58Β means that Merck & Co. Inc assets areΒ financed with 58.0% credit (debt) and the remaining percentage (100% - 58.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.580. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.604. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.580TTM0.604-0.025
TTM0.604YOY0.627-0.023
TTM0.6045Y0.627-0.023
5Y0.62710Y0.637-0.010
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5800.556+0.024
TTM0.6040.564+0.040
YOY0.6270.540+0.087
3Y0.6040.539+0.065
5Y0.6270.567+0.060
10Y0.6370.577+0.060
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Merck & Co. Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • A Debt to Equity ratio of 138.0% means that company has €1.38 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Co. Inc:

  • The MRQ is 1.380. The company is able to pay all its debts with equity. +1
  • The TTM is 1.533. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.380TTM1.533-0.152
TTM1.533YOY1.686-0.153
TTM1.5335Y1.723-0.191
5Y1.72310Y1.803-0.080
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3801.270+0.110
TTM1.5331.359+0.174
YOY1.6861.259+0.427
3Y1.5361.439+0.097
5Y1.7231.433+0.290
10Y1.8031.478+0.325
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Merck & Co. Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Merck & Co. Inc to theΒ Other industry mean.
  • A PE ratio of 12.18 means the investor is paying €12.18Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Co. Inc:

  • The EOD is 10.195. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.184. Based on the earnings, the company is underpriced. +1
  • The TTM is 17.961. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD10.195MRQ12.184-1.989
MRQ12.184TTM17.961-5.777
TTM17.961YOY-9.672+27.633
TTM17.9615Y10.817+7.144
5Y10.81710Y10.263+0.554
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD10.19512.867-2.672
MRQ12.18413.609-1.425
TTM17.96112.438+5.523
YOY-9.67212.113-21.785
3Y10.15310.003+0.150
5Y10.81713.781-2.964
10Y10.26312.889-2.626
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Merck & Co. Inc:

  • The EOD is 44.182. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 52.803. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 27.176. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD44.182MRQ52.803-8.621
MRQ52.803TTM27.176+25.627
TTM27.176YOY-4.586+31.762
TTM27.1765Y31.433-4.257
5Y31.43310Y18.056+13.377
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD44.1825.075+39.107
MRQ52.8035.497+47.306
TTM27.1765.735+21.441
YOY-4.5864.130-8.716
3Y30.8410.265+30.576
5Y31.4333.402+28.031
10Y18.0561.825+16.231
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Merck & Co. Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Other industry mean).
  • A PB ratio of 5.11 means the investor is paying €5.11Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Co. Inc:

  • The EOD is 4.279. Based on the equity, the company is fair priced.
  • The MRQ is 5.114. Based on the equity, the company is overpriced. -1
  • The TTM is 6.586. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.279MRQ5.114-0.835
MRQ5.114TTM6.586-1.472
TTM6.586YOY8.023-1.437
TTM6.5865Y6.689-0.103
5Y6.68910Y6.013+0.676
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD4.2791.240+3.039
MRQ5.1141.255+3.859
TTM6.5861.311+5.275
YOY8.0231.306+6.717
3Y6.9511.317+5.634
5Y6.6891.634+5.055
10Y6.0131.572+4.441
4.6.2. Total Gains per Share

2.4. Latest News of Merck & Co. Inc

Does Merck & Co. Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Merck & Co. Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-02
21:17
Merck's HPV Vaccine Gardasil Remains Key Driver Ahead of Q2 Results, UBS SaysRead
2025-07-02
19:38
Merck (NYSE:MRK) Gains FDA Priority Review For WINREVAIR PAH Treatment sBLARead
2025-07-01
18:10
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?Read
2025-06-28
11:41
Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION TrialRead
2025-06-28
08:15
Should You Count on MRK for Steady Passive Income?Read
2025-06-26
23:50
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to KnowRead
2025-06-26
19:39
ACIP Recommends Use of Merck’s ENFLONSIAβ„’ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV SeasonRead
2025-06-24
23:21
Jefferies Reaffirms Merck (MRK) β€˜Buy’ Rating on Gardasil Dosing StabilityRead
2025-06-20
20:06
The 5 Most Interesting Analyst Questions From Merck’s Q1 Earnings CallRead
2025-06-18
23:45
Why the Market Dipped But Merck (MRK) Gained TodayRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets115,122,000
Total Liabilities66,722,000
Total Stockholder Equity48,335,000
 As reported
Total Liabilities 66,722,000
Total Stockholder Equity+ 48,335,000
Total Assets = 115,122,000

Assets

Total Assets115,122,000
Total Current Assets35,503,000
Long-term Assets79,619,000
Total Current Assets
Cash And Cash Equivalents 8,629,000
Short-term Investments 599,000
Net Receivables 10,790,000
Inventory 6,196,000
Other Current Assets 9,289,000
Total Current Assets  (as reported)35,503,000
Total Current Assets  (calculated)35,503,000
+/-0
Long-term Assets
Property Plant Equipment 24,793,000
Goodwill 21,684,000
Long Term Investments 616,000
Intangible Assets 15,758,000
Long-term Assets Other 16,768,000
Long-term Assets  (as reported)79,619,000
Long-term Assets  (calculated)79,619,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,174,000
Long-term Liabilities41,548,000
Total Stockholder Equity48,335,000
Total Current Liabilities
Short Long Term Debt 1,360,000
Accounts payable 3,784,000
Total Current Liabilities  (as reported)25,174,000
Total Current Liabilities  (calculated)5,144,000
+/- 20,030,000
Long-term Liabilities
Long term Debt 33,484,000
Long-term Liabilities Other 6,655,000
Long-term Liabilities  (as reported)41,548,000
Long-term Liabilities  (calculated)40,139,000
+/- 1,409,000
Total Stockholder Equity
Retained Earnings 66,097,000
Total Stockholder Equity (as reported)48,335,000
Total Stockholder Equity (calculated)66,097,000
+/- 17,762,000
Other
Capital Stock1,788,000
Common Stock Shares Outstanding 2,516,394
Net Debt 26,215,000
Net Invested Capital 83,179,000
Net Working Capital 10,329,000
Property Plant and Equipment Gross 44,473,000



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
82,354,000
83,965,000
83,331,000
84,397,000
84,913,000
90,615,000
89,800,000
91,588,000
90,847,000
90,688,000
93,494,000
105,694,000
106,668,000
107,095,000
107,081,000
109,160,000
107,796,000
104,469,000
106,727,000
106,675,000
105,849,000
112,630,000
117,532,000
117,106,000
115,122,000
115,122,000117,106,000117,532,000112,630,000105,849,000106,675,000106,727,000104,469,000107,796,000109,160,000107,081,000107,095,000106,668,000105,694,00093,494,00090,688,00090,847,00091,588,00089,800,00090,615,00084,913,00084,397,00083,331,00083,965,00082,354,000
   > Total Current Assets 
25,351,000
24,298,000
26,142,000
27,483,000
26,174,000
29,343,000
26,577,000
27,764,000
26,909,000
28,665,000
31,058,000
30,266,000
31,184,000
32,116,000
33,561,000
35,722,000
33,402,000
29,977,000
31,954,000
32,168,000
31,445,000
38,205,000
40,361,000
38,782,000
35,503,000
35,503,00038,782,00040,361,00038,205,00031,445,00032,168,00031,954,00029,977,00033,402,00035,722,00033,561,00032,116,00031,184,00030,266,00031,058,00028,665,00026,909,00027,764,00026,577,00029,343,00026,174,00027,483,00026,142,00024,298,00025,351,000
       Cash And Cash Equivalents 
8,076,000
6,659,000
7,869,000
9,676,000
7,425,000
11,103,000
7,356,000
8,062,000
6,981,000
8,575,000
10,016,000
8,096,000
8,556,000
9,675,000
11,145,000
12,694,000
9,707,000
5,660,000
8,605,000
6,841,000
5,579,000
11,304,000
14,593,000
13,242,000
8,629,000
8,629,00013,242,00014,593,00011,304,0005,579,0006,841,0008,605,0005,660,0009,707,00012,694,00011,145,0009,675,0008,556,0008,096,00010,016,0008,575,0006,981,0008,062,0007,356,00011,103,0007,425,0009,676,0007,869,0006,659,0008,076,000
       Short-term Investments 
722,000
446,000
149,000
774,000
7,000
0
0
0
0
0
0
0
372,000
453,000
103,000
498,000
680,000
718,000
168,000
252,000
40,000
50,000
0
447,000
599,000
599,000447,000050,00040,000252,000168,000718,000680,000498,000103,000453,000372,00000000007,000774,000149,000446,000722,000
       Net Receivables 
7,608,000
7,964,000
8,442,000
6,778,000
8,182,000
7,577,000
8,422,000
7,851,000
8,235,000
7,843,000
8,571,000
9,230,000
9,828,000
9,643,000
9,482,000
9,450,000
10,415,000
11,030,000
10,394,000
10,349,000
11,366,000
11,642,000
11,381,000
10,278,000
10,790,000
10,790,00010,278,00011,381,00011,642,00011,366,00010,349,00010,394,00011,030,00010,415,0009,450,0009,482,0009,643,0009,828,0009,230,0008,571,0007,843,0008,235,0007,851,0008,422,0007,577,0008,182,0006,778,0008,442,0007,964,0007,608,000
       Inventory 
5,712,000
5,847,000
7,370,000
5,978,000
7,476,000
7,977,000
8,209,000
6,310,000
8,577,000
7,911,000
7,976,000
5,953,000
5,774,000
5,535,000
5,614,000
5,911,000
5,863,000
5,930,000
6,131,000
6,358,000
6,510,000
6,469,000
6,244,000
6,109,000
6,196,000
6,196,0006,109,0006,244,0006,469,0006,510,0006,358,0006,131,0005,930,0005,863,0005,911,0005,614,0005,535,0005,774,0005,953,0007,976,0007,911,0008,577,0006,310,0008,209,0007,977,0007,476,0005,978,0007,370,0005,847,0005,712,000
       Other Current Assets 
3,233,000
3,382,000
2,312,000
4,277,000
3,084,000
2,686,000
2,590,000
5,541,000
3,116,000
4,336,000
4,495,000
6,987,000
6,654,000
6,810,000
7,217,000
7,169,000
6,737,000
6,639,000
6,656,000
8,368,000
7,950,000
8,740,000
8,143,000
8,706,000
9,289,000
9,289,0008,706,0008,143,0008,740,0007,950,0008,368,0006,656,0006,639,0006,737,0007,169,0007,217,0006,810,0006,654,0006,987,0004,495,0004,336,0003,116,0005,541,0002,590,0002,686,0003,084,0004,277,0002,312,0003,382,0003,233,000
   > Long-term Assets 
57,003,000
59,667,000
57,189,000
56,914,000
58,739,000
61,272,000
63,223,000
63,824,000
63,938,000
62,023,000
62,436,000
75,428,000
75,484,000
74,979,000
73,520,000
73,438,000
74,394,000
74,492,000
74,773,000
74,507,000
74,404,000
74,425,000
77,171,000
78,324,000
79,619,000
79,619,00078,324,00077,171,00074,425,00074,404,00074,507,00074,773,00074,492,00074,394,00073,438,00073,520,00074,979,00075,484,00075,428,00062,436,00062,023,00063,938,00063,824,00063,223,00061,272,00058,739,00056,914,00057,189,00059,667,00057,003,000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,424,000
21,422,000
21,758,000
22,231,000
22,526,000
23,051,000
23,045,000
23,221,000
23,446,000
23,779,000
24,793,000
24,793,00023,779,00023,446,00023,221,00023,045,00023,051,00022,526,00022,231,00021,758,00021,422,00020,424,00000000000000000
       Goodwill 
18,170,000
19,490,000
19,480,000
19,425,000
19,767,000
20,067,000
20,248,000
20,238,000
20,212,000
18,873,000
18,862,000
21,264,000
21,258,000
21,213,000
21,160,000
21,204,000
21,209,000
21,195,000
21,183,000
21,197,000
21,181,000
21,161,000
21,697,000
21,668,000
21,684,000
21,684,00021,668,00021,697,00021,161,00021,181,00021,197,00021,183,00021,195,00021,209,00021,204,00021,160,00021,213,00021,258,00021,264,00018,862,00018,873,00020,212,00020,238,00020,248,00020,067,00019,767,00019,425,00019,480,00019,490,00018,170,000
       Long Term Investments 
5,621,000
3,779,000
2,111,000
1,469,000
555,000
1,251,000
1,372,000
785,000
544,000
411,000
435,000
370,000
316,000
238,000
984,000
1,015,000
1,290,000
1,214,000
1,306,000
252,000
280,000
357,000
575,000
463,000
616,000
616,000463,000575,000357,000280,000252,0001,306,0001,214,0001,290,0001,015,000984,000238,000316,000370,000435,000411,000544,000785,0001,372,0001,251,000555,0001,469,0002,111,0003,779,0005,621,000
       Intangible Assets 
10,999,000
13,381,000
12,307,000
14,196,000
16,096,000
16,566,000
16,677,000
14,604,000
14,401,000
13,622,000
13,384,000
22,933,000
23,022,000
22,497,000
21,368,000
20,269,000
19,857,000
19,665,000
19,199,000
18,011,000
17,572,000
16,984,000
17,010,000
16,370,000
15,758,000
15,758,00016,370,00017,010,00016,984,00017,572,00018,011,00019,199,00019,665,00019,857,00020,269,00021,368,00022,497,00023,022,00022,933,00013,384,00013,622,00014,401,00014,604,00016,677,00016,566,00016,096,00014,196,00012,307,00013,381,00010,999,000
       Long-term Assets Other 
8,707,000
9,155,000
9,004,000
6,771,000
7,052,000
7,599,000
8,007,000
10,211,000
10,486,000
11,053,000
11,190,000
11,582,000
11,141,000
10,972,000
9,584,000
9,528,000
10,280,000
10,187,000
10,559,000
11,996,000
12,326,000
12,702,000
14,443,000
16,044,000
16,768,000
16,768,00016,044,00014,443,00012,702,00012,326,00011,996,00010,559,00010,187,00010,280,0009,528,0009,584,00010,972,00011,141,00011,582,00011,190,00011,053,00010,486,00010,211,0008,007,0007,599,0007,052,0006,771,0009,004,0009,155,0008,707,000
> Total Liabilities 
54,684,000
56,228,000
56,406,000
58,396,000
58,613,000
62,871,000
60,530,000
66,184,000
63,808,000
57,300,000
57,631,000
67,437,000
65,715,000
63,777,000
62,557,000
63,102,000
60,891,000
65,727,000
65,427,000
69,040,000
65,425,000
68,982,000
72,972,000
70,734,000
66,722,000
66,722,00070,734,00072,972,00068,982,00065,425,00069,040,00065,427,00065,727,00060,891,00063,102,00062,557,00063,777,00065,715,00067,437,00057,631,00057,300,00063,808,00066,184,00060,530,00062,871,00058,613,00058,396,00056,406,00056,228,00054,684,000
   > Total Current Liabilities 
18,543,000
20,085,000
20,684,000
22,220,000
23,483,000
22,178,000
20,405,000
27,327,000
26,361,000
21,906,000
23,728,000
23,872,000
22,316,000
23,168,000
22,998,000
24,239,000
23,131,000
23,394,000
23,094,000
25,694,000
25,099,000
26,060,000
29,586,000
28,420,000
25,174,000
25,174,00028,420,00029,586,00026,060,00025,099,00025,694,00023,094,00023,394,00023,131,00024,239,00022,998,00023,168,00022,316,00023,872,00023,728,00021,906,00026,361,00027,327,00020,405,00022,178,00023,483,00022,220,00020,684,00020,085,00018,543,000
       Short-term Debt 
3,175,000
3,816,000
3,411,000
3,610,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003,610,0003,411,0003,816,0003,175,000
       Short Long Term Debt 
3,175,000
3,816,000
3,411,000
3,610,000
6,361,000
4,718,000
2,420,000
6,431,000
7,251,000
2,488,000
3,534,000
2,412,000
1,208,000
2,979,000
1,936,000
1,946,000
2,672,000
2,839,000
887,000
1,372,000
3,077,000
3,071,000
3,149,000
2,649,000
1,360,000
1,360,0002,649,0003,149,0003,071,0003,077,0001,372,000887,0002,839,0002,672,0001,946,0001,936,0002,979,0001,208,0002,412,0003,534,0002,488,0007,251,0006,431,0002,420,0004,718,0006,361,0003,610,0003,411,0003,816,0003,175,000
       Accounts payable 
3,018,000
3,142,000
3,198,000
3,738,000
3,572,000
3,448,000
3,744,000
4,594,000
4,034,000
3,897,000
3,366,000
4,609,000
3,715,000
3,482,000
3,371,000
4,264,000
3,680,000
3,442,000
3,509,000
3,922,000
3,514,000
3,519,000
3,586,000
4,079,000
3,784,000
3,784,0004,079,0003,586,0003,519,0003,514,0003,922,0003,509,0003,442,0003,680,0004,264,0003,371,0003,482,0003,715,0004,609,0003,366,0003,897,0004,034,0004,594,0003,744,0003,448,0003,572,0003,738,0003,198,0003,142,0003,018,000
   > Long-term Liabilities 
36,141,000
36,143,000
35,722,000
36,176,000
35,130,000
40,693,000
40,125,000
38,857,000
37,447,000
35,394,000
33,903,000
43,565,000
43,399,000
40,609,000
39,559,000
38,863,000
37,760,000
42,333,000
42,333,000
43,346,000
40,326,000
42,922,000
43,386,000
42,314,000
41,548,000
41,548,00042,314,00043,386,00042,922,00040,326,00043,346,00042,333,00042,333,00037,760,00038,863,00039,559,00040,609,00043,399,00043,565,00033,903,00035,394,00037,447,00038,857,00040,125,00040,693,00035,130,00036,176,00035,722,00036,143,00036,141,000
       Long term Debt 
22,721,000
22,771,000
22,677,000
22,736,000
21,637,000
26,156,000
26,321,000
25,360,000
24,002,000
24,033,000
22,907,000
30,690,000
30,586,000
28,684,000
28,482,000
28,745,000
28,074,000
34,072,000
33,972,000
33,683,000
31,142,000
34,717,000
34,982,000
34,462,000
33,484,000
33,484,00034,462,00034,982,00034,717,00031,142,00033,683,00033,972,00034,072,00028,074,00028,745,00028,482,00028,684,00030,586,00030,690,00022,907,00024,033,00024,002,00025,360,00026,321,00026,156,00021,637,00022,736,00022,677,00022,771,00022,721,000
       Long-term Liabilities Other 
11,585,000
11,283,000
11,085,000
11,970,000
11,550,000
12,446,000
12,027,000
12,482,000
12,241,000
9,872,000
9,469,000
9,434,000
9,742,000
8,951,000
8,660,000
8,323,000
8,244,000
7,265,000
7,343,000
8,792,000
8,262,000
7,329,000
7,540,000
6,465,000
6,655,000
6,655,0006,465,0007,540,0007,329,0008,262,0008,792,0007,343,0007,265,0008,244,0008,323,0008,660,0008,951,0009,742,0009,434,0009,469,0009,872,00012,241,00012,482,00012,027,00012,446,00011,550,00011,970,00011,085,00011,283,00011,585,000
> Total Stockholder Equity
27,539,000
27,635,000
26,838,000
25,907,000
26,205,000
27,642,000
29,186,000
25,317,000
26,945,000
33,294,000
35,794,000
38,184,000
40,883,000
43,243,000
44,458,000
45,991,000
46,834,000
38,693,000
41,246,000
37,581,000
40,364,000
43,582,000
44,502,000
46,313,000
48,335,000
48,335,00046,313,00044,502,00043,582,00040,364,00037,581,00041,246,00038,693,00046,834,00045,991,00044,458,00043,243,00040,883,00038,184,00035,794,00033,294,00026,945,00025,317,00029,186,00027,642,00026,205,00025,907,00026,838,00027,635,00027,539,000
   Common Stock0000000000000000000000000
   Retained Earnings 
44,065,000
45,295,000
45,804,000
46,602,000
48,272,000
49,724,000
51,107,000
47,362,000
48,888,000
48,777,000
51,691,000
53,696,000
56,252,000
58,437,000
59,928,000
61,081,000
62,039,000
54,198,000
57,082,000
53,895,000
56,697,000
60,187,000
61,384,000
63,069,000
66,097,000
66,097,00063,069,00061,384,00060,187,00056,697,00053,895,00057,082,00054,198,00062,039,00061,081,00059,928,00058,437,00056,252,00053,696,00051,691,00048,777,00048,888,00047,362,00051,107,00049,724,00048,272,00046,602,00045,804,00045,295,00044,065,000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue64,168,000
Cost of Revenue-15,193,000
Gross Profit48,975,00048,975,000
 
Operating Income (+$)
Gross Profit48,975,000
Operating Expense-43,947,000
Operating Income20,221,0005,028,000
 
Operating Expense (+$)
Research Development17,938,000
Selling General Administrative10,816,000
Selling And Marketing Expenses-
Operating Expense43,947,00028,754,000
 
Net Interest Income (+$)
Interest Income415,000
Interest Expense-1,271,000
Other Finance Cost-0
Net Interest Income-856,000
 
Pretax Income (+$)
Operating Income20,221,000
Net Interest Income-856,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)19,936,00019,650,000
EBIT - interestExpense = -1,271,000
17,117,000
18,388,000
Interest Expense1,271,000
Earnings Before Interest and Taxes (EBIT)-21,207,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax19,936,000
Tax Provision-2,803,000
Net Income From Continuing Ops17,133,00017,133,000
Net Income17,117,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net571,000856,000
 

Technical Analysis of Merck & Co. Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Merck & Co. Inc. The general trend of Merck & Co. Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Merck & Co. Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Merck & Co. Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Merck & Co. Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 67.20 < 70.20 < 70.30.

The bearish price targets are: 66.04 > 65.64.

Know someone who trades $6MK? Share this with them.πŸ‘‡

Merck & Co. Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Merck & Co. Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Merck & Co. Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Merck & Co. Inc.

Merck & Co. Inc Daily Moving Average Convergence/Divergence (MACD) ChartMerck & Co. Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Merck & Co. Inc. The current adx is .

Merck & Co. Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Merck & Co. Inc.

Merck & Co. Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Merck & Co. Inc.

Merck & Co. Inc Daily Relative Strength Index (RSI) ChartMerck & Co. Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Merck & Co. Inc.

Merck & Co. Inc Daily Stochastic Oscillator ChartMerck & Co. Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Merck & Co. Inc.

Merck & Co. Inc Daily Commodity Channel Index (CCI) ChartMerck & Co. Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Merck & Co. Inc.

Merck & Co. Inc Daily Chande Momentum Oscillator (CMO) ChartMerck & Co. Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Merck & Co. Inc.

Merck & Co. Inc Daily Williams %R ChartMerck & Co. Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Merck & Co. Inc.

Merck & Co. Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Merck & Co. Inc.

Merck & Co. Inc Daily Average True Range (ATR) ChartMerck & Co. Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Merck & Co. Inc.

Merck & Co. Inc Daily On-Balance Volume (OBV) ChartMerck & Co. Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Merck & Co. Inc.

Merck & Co. Inc Daily Money Flow Index (MFI) ChartMerck & Co. Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Merck & Co. Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Merck & Co. Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Merck & Co. Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose69.500
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Merck & Co. Inc with someone you think should read this too:
  • Are you bullish or bearish on Merck & Co. Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Merck & Co. Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Merck & Co. Inc

I send you an email if I find something interesting about Merck & Co. Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Merck & Co. Inc.

Receive notifications about Merck & Co. Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.